0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2010;170(6):506. doi:10.1001/archinternmed.2010.19.
Text Size: A A A
Published online

CANCER THEME

We are pleased to highlight in this issue our Cancer theme and thank Charles L. Bennett, MD, PhD, Editorial Board Member, for serving as Guest Editor for these articles.

B-TYPE NATRIURETIC PEPTIDE–GUIDED HEART FAILURE THERAPY

This meta-analysis evaluated the potential clinical benefits of B-type natriuretic peptide (BNP)-guided therapy in chronic systolic heart failure. Porapakkham et al found that BNP-guided therapy reduces all-cause mortality in patients with chronic heart failure when compared with usual clinical care, specifically in patients younger than 75 years. However, there does not appear to be a reduction in all-cause hospitalization or increase in survival free of hospitalization using this approach. The cost-effectiveness of BNP-guided therapy also needs to be ascertained before it can be considered for routine use in clinical practice.

See Article

INDIVIDUALIZED MEDICAL DECISION MAKING

Fraenkel and Fried present the clinical scenario of anticoagulation in nonvalvular atrial fibrillation (NVAF), in which benefits (ie, stroke risk reduction) and harms (ie, increased bleeding risk) of treatment vary considerably, such that the benefit to harm ratio can reverse according to the patients' specific comorbid conditions. Despite the wealth of studies in NVAF, many assumptions are necessary to calculate patient-specific outcomes, and these assumptions may lead to substantial overestimation or underestimation of benefits and harms. The ability to provide accurate and comprehensive individualized outcome assessments will require substantive increases in the efforts and resources allocated toward the collection and dissemination of outcome data for patients with varying comorbidities.

See Article

CANCER AND THE MEDIA: HOW DOES THE NEWS REPORT ON TREATMENT AND OUTCOMES?

Cancer receives a great deal of news media attention. Although approximately half of US patients with cancer will die of their illness or related complications, it is not known whether reports in the news media reflect this reality. This study examined newspapers and national magazines to determine how news coverage reports on cancer care and outcomes. Fishman et al found that news reports frequently discuss aggressive cancer treatment and survival but rarely discuss treatment failure, adverse events, mortality, or end-of-life care. These portrayals of cancer care may give patients an inappropriately optimistic view of cancer treatment, outcomes, and prognosis.

See Article

TIMELY CARE AFTER AN ABNORMAL MAMMOGRAM AMONG LOW-INCOME WOMEN IN A PUBLIC BREAST CANCER SCREENING PROGRAM

Interest in expanding health insurance to all Americans has placed new emphasis on the benefit of existing public health programs for low-income, underinsured populations. In a time-to-event analysis, with pre-post comparisons, Lobb et al examined timely follow-up after an abnormal mammogram for 2252 participants in the Massachusetts National Breast and Cervical Cancer Early Detection Program. After the introduction of case management, adjusted risk of diagnostic delay (>60 days) decreased by 35%, and the decrease did not differ by race/ethnicity. The adjusted risk of treatment delay (>90 days) was not associated with case management, and implementation of free treatment was not associated with diagnostic or treatment delay beyond improvements following the introduction of case management. These findings suggest that services to coordinate care, in addition to providing coverage for care, may be required to improve health outcomes for low-income women.

See Article

BUPROPION AND COGNITIVE BEHAVIORAL THERAPY FOR WEIGHT-CONCERNED WOMEN SMOKERS

There is evidence that women's concerns about weight gain negatively affect smoking cessation efforts. Cognitive behavioral therapy for smoking-related weight concerns has been shown to improve cessation rates, but the impact of combining this treatment with cessation medication is unknown. In a randomized controlled trial, Levine et al examined whether medication (bupropion hydrochloride [B] or placebo [P]) enhanced the effect of a smoking cessation intervention that incorporated treatment for weight concerns. Women (N = 349) who received the weight concerns counseling (CONCERNS) + B were more likely to be abstinent during 24 weeks of treatment than were women who received either standard smoking cessation intervention (STANDARD) + B or CONCERNS + P. The combination of CONCERNS + B is efficacious for weight-concerned women smokers.

See Article

Place holder to copy figure label and caption

Time to relapse by treatment group.

Graphic Jump Location

Figures

Place holder to copy figure label and caption

Time to relapse by treatment group.

Graphic Jump Location

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.